1 J. Mol. Neurosci. 2015 Dec 57: 519-21
PMID 26231937
Title XPR1: a Gene Linked to Primary Familial Brain Calcification Might Help Explain a Spectrum of Neuropsychiatric Disorders.
Abstract Primary familial brain calcifications (PFBC) compose a rare neurologic condition characterized by a bilateral pattern of hydroxyapatite deposits in basal ganglia, dentate nuclei, and thalamus. PFBC is identified through neuroimaging screenings such as computerized tomography. Patients with PFBC might present a wide variety of neurological symptoms such as mental and motor impairments, often misdiagnosed as Parkinson's disease,精神分裂症, Alzheimer's disease, and migraine. Four genes were confirmed as causative of PFBC:SLC20A2, PDGFB, PDGFRB, and XPR1. Curiously, other studies made occasional links between XPR1 variations or expression changes, in a few neuropsychiatric models. This letter is an assembly on XPR1 variants and expression change pattern data that were published in recent scientific reports, even before the current connection between that gene and brain calcification.
SCZ Keywords 精神分裂症
2 Psychiatry Clin. Neurosci. 2015 Feb 69: 77-83
PMID 25211641
Title First Japanese family with primary familial brain calcification due to a mutation in the PDGFB gene: an exome analysis study.
Abstract Primary familial brain calcification (PFBC) is a rare disorder characterized by abnormal deposits of calcium in the basal ganglia and cerebellum. PFBC can present with a spectrum of neuropsychiatric symptoms resembling those seen in dementia and精神分裂症. Mutations in a few genes have been identified as causing PFBC: namely, theSLC20A2gene that codes for the sodium-dependent phosphate transporter and the PDGFRB gene that codes for the platelet-derived growth factor receptor ? (PDGF-R?). A recent study identified mutations in PDGFB coding for PDGF-B, the main ligand for PDGF-R?, in six families with PFBC. Here we report the first Japanese family with PFBC carrying a mutation in PDGFB, which causes the substitution of an arginine with a stop codon at amino acid 149 of the PDGF-B protein (p. Arg149*).
Clinical histories and computed tomography scan images were provided. Sanger sequencing was performed for the exome analysis ofSLC20A2and PDGFB genes.
One family member began to complain of auditory hallucination at 16 years of age and had been treated for精神分裂症. His father suffered from memory and gait disturbances in his late 60s. A computed tomography scan revealed a symmetrical area of calcification over the basal ganglia in both cases. A known mutation in PDGFB (c.445C>T, p.Arg149*) was consistently detected in both PFBC cases by Sanger sequencing. No mutations inSLC20A2were detected.
Our findings suggest that this mutation in PDGF-B is responsible for PFBC in this Japanese family and that abnormal PDGF signaling may be involved in the pathophysiology of certain psychiatric disorders.
SCZ Keywords 精神分裂症
Baidu